Evaluating the discontinuation rates of the two-injection aripiprazole long-acting injection initiation regime.
Aripiprazole long-acting injection is an effective medication for treating schizophrenia, and a new regime for initiating aripiprazole has been licensed. The project aims to assess whether the two-injection regime improves discontinuation rates of aripiprazole.